Efficacy of Deferasirox as an Oral Iron Chelator in Paediatric Thalassaemia Patients

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 2

Abstract

Introduction: Thalassaemia Major patients require frequent blood transfusion leading to iron overload. Excessive iron gets deposited in vital organs and leads to dysfunction of the heart, liver, anterior pituitary, pancreas, and joints. Our body has limited mechanism to excrete iron, so patients with iron overload and its complications need safe and effective iron chelation therapy. Aim: To assess the efficacy of Deferasirox (DFX) as an iron chelator, with specific reference to reduction in serum ferritin level. Materials and Methods: This is a prospective; observational study done in 45 multitransfused Thalassaemia Major Children receiving DFX therapy at registered Thalassaemia society Raipur Chhattisgarh. DFX was given in an initial dose of 20 mg/kg/day and according to response increased to a maximum of 40 mg/kg/ day. Serum ferritin level was estimated at time of registration and at every three monthly intervals (four times during study period). The primary end point of the study was change in serum ferritin level after 12 months of DFX therapy. Results: The mean serum ferritin before DFX therapy of all cases was 3727.02 ng/mL. After 12 months of mean dose of 38 mg/kg/ day of DFX, the mean decline in serum ferritin was 1207.11 ng/ mL (drop by 32.38%, p-value <0.001). Conclusion: DFX monotherapy has a good safety profile and effectively chelates total body iron in Thalassaemia major patients.

Authors and Affiliations

Shikha Jaiswal, Rajesh Hishikar, Onkar Khandwal, Manju Agarwal, Usha Joshi, Ajay Halwai, Basant Maheshwari, Raka Sheohare

Keywords

Related Articles

Maxillary Second Molar with Fused Root and Six Canals- A Case Report

One of the known aberrations in root canal morphology of maxillary second permanent molars is the presence of collateral mesiobuccal canals. This case report describes the endodontic management of a maxillary second mola...

Surgical Implications of Portal Vein Variations and Liver Segmentations: A Recent Update

The Couinaud’s liver segmentation is based on the identification of portal vein bifurcation and origin of hepatic veins. It is widely used clinically, because it is better suited for surgery and is more accurate in local...

Respiratory Symptoms as Prominent Manifestation of Brucellosis: A Case Series

Brucellosis is a zoonotic infection primarily affecting the reticuoendothelial system: spleen, liver and bone marrow. Despite the fact that multisystem infection in brucellosis is usually reported, pulmonary involvement...

Trichoadenoma of Nikolowski- A Rare Tumour with Unusual Presentation Over Vulva

Trichoadenoma is a rare benign, slowly growing, cutaneous tumour of the hair follicle first described by Nikolowski in 1958. It presents as a non-specific nodule over the face or buttocks. However, unusual sites such as...

Large Placenta and Small Foetus at Early Gestation Predicts Foetal Growth Restriction due to Placental Dysmorphology

ABSTRACT When placenta appears large on ultrasound, there are certain differential diagnoses to be kept in mind. We present a series of three cases in which large placenta was observed in first trimester scan. All three...

Download PDF file
  • EP ID EP332147
  • DOI 10.7860/JCDR/2017/22650.9395
  • Views 114
  • Downloads 0

How To Cite

Shikha Jaiswal, Rajesh Hishikar, Onkar Khandwal, Manju Agarwal, Usha Joshi, Ajay Halwai, Basant Maheshwari, Raka Sheohare (2017). Efficacy of Deferasirox as an Oral Iron Chelator in Paediatric Thalassaemia Patients. Journal of Clinical and Diagnostic Research, 11(2), 1-3. https://europub.co.uk/articles/-A-332147